Differing effects of denosumab and alendronate on cortical and trabecular boneRoger Zebaze, Ego Seeman, Cesar Libanati et al.|Bone|2013Cited by 155
Denosumab Reduces Cortical Porosity of the Proximal Femoral Shaft in Postmenopausal Women With OsteoporosisRoger Zebaze, Ego Seeman, Cesar Libanati et al.|Journal of Bone and Mineral Research|2016Cited by 79
Risedronate Slows or Partly Reverses Cortical and Trabecular Microarchitectural Deterioration in Postmenopausal WomenYohann Bala, René Rizzoli, Roland Chapurlat et al.|Journal of Bone and Mineral Research|2013Cited by 41
Denosumab treatment in women with osteoporosis reduces hip cortical porosityRoger Zebaze, Ego Seeman, Cesar Libanati et al.|Bone Abstracts|2014Cited by 1
SAT0457 Reduced Hip Cortical Porosity with Denosumab (DMAB) Treatment in Women with OsteoporosisR Zebaze, Ego Seeman, Cesar Libanati et al.|Annals of the Rheumatic Diseases|2014Cited by 0